Neuroscience 2017. Drugs repositioning for neurodegenerative disorders
The drug development process consumes significant amounts of time and resources. Whether an initial project’s primary goal was achieved or not, documented findings can still potentially contribute to future discoveries. Luckily, vast amounts of knowledge are produced in the form of lab notebooks, grant applications, research papers, and clinical studies reports.
To make the most from the immense amount of global research communication we created sci.AI platform. The idea is to make all the open access (OA) papers machine readable, create a useful knowledge graph, and define drugs to be repositioned based on the resulting connections found.
Due to economic and time pressures in de novo drug development, drug repositioning is a particularly valuable way of carrying out discovery.
We will tell how to repurpose drugs for neurodegenerative disorders at Neuroscience 2017
It is a great opportunity to meet, network, and have one-on-one discussions as well.
Drop us a mail at email@example.com to pre-book a one-on-one session or just leave your email in the form below
We look forward to seeing you at Neuroscience 2017!
Related info and materials:
- Session Type: Poster
- Session Number: 721
- Session Title: Software Tools II
- Speach Name: How to find candidate drugs to be repositioned for neurodegenerative disorders within a graph of globally-connected, machine-readable papers
- Date and Time: Wednesday Nov 15, 2017 8:00 AM – 12:00 PM
- Location: Walter E. Washington Convention Center: Halls A-C
- Abstract Control Number: 13733
The post will be updated time to time. We will add news and materials related to the event.
Follow us to don’t miss updates